- Report
- January 2025
- 175 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- January 2025
- 175 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- November 2024
- 180 Pages
Global
From €4003EUR$4,500USD£3,473GBP
- Report
- November 2024
- 88 Pages
India
From €3114EUR$3,500USD£2,701GBP
- Report
- April 2024
- 183 Pages
Global
From €4003EUR$4,500USD£3,473GBP
- Report
- October 2023
- 90 Pages
India
From €3114EUR$3,500USD£2,701GBP
- Report
- October 2023
- 73 Pages
Malaysia
From €3114EUR$3,500USD£2,701GBP
From €3114EUR$3,500USD£2,701GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €3114EUR$3,500USD£2,701GBP
- Report
- November 2023
- 182 Pages
Global
From €4003EUR$4,500USD£3,473GBP
- Report
- February 2024
- 131 Pages
Global
From €4226EUR$4,750USD£3,666GBP
- Report
- October 2022
- 110 Pages
Global
From €4226EUR$4,750USD£3,666GBP
- Report
- August 2022
- 117 Pages
Global
From €4226EUR$4,750USD£3,666GBP
- Report
- January 2025
- 136 Pages
Global
From €2668EUR$2,999USD£2,315GBP
- Report
- May 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,203GBP
- Report
- March 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,203GBP
- Report
- March 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,203GBP
- Report
- March 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,203GBP
- Report
- January 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,203GBP
- Report
- January 2024
- 200 Pages
Global
From €3692EUR$4,150USD£3,203GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more